Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
United States Model updates for September 11, 2020
covid.healthdata.org Institute for Health Metrics and Evaluation
COVID-19 remained steady in the US over the last week while mobility and mask use continued to worsen. We expect a major surge in daily cases and deaths in November and December driven by seasonality and decreased vigilance.
Current situation
• The decline in national case numbers seen since late July flattened in the last week (Figure 1). • Daily deaths have been relatively constant around 850 per day over the past week so that COVID-19 remains the
number two cause of death in the US (Figure 2 and Table 1). • States where the combination of data on cases, hospitalizations, and deaths suggest that transmission is
increasing has shifted to Alabama, Colorado, Hawaii, Kansas, Missouri, New Jersey, New York, Virginia, and West Virginia (Figure 3).
• States where the COVID-19 death rate is over 4 per million are in a contiguous block from Texas through to South Carolina (Figure 6).
Trends in key drivers of transmission (mobility, mask use, testing, and seasonality)
• Evidence is consistently emerging that the US is becoming less vigilant. Mobility has been rising since August 1, albeit slowly (Figure 8).
• Mask use, as measured in the PREMISE surveys based on the response category of “always wear a mask when leaving home,” has also been declining steadily since August 1. Only six states have mask use over 50% at this point: Alaska, California, Florida, Hawaii, Texas, and Virginia (Figure 9).
Projections
• We expect the daily death rate in the US, because of seasonality and declining public vigilance, to reach nearly 3,000 a day in December. Cumulative deaths expected by January 1 are 415,090; this is 222,522 deaths from now until the end of the year.
• The large increase in daily deaths expected in late November and December is driven by continued increases in mobility, declines in mask use, and – most importantly – seasonality. We estimate the likely impact of seasonality by examining the trends in the Northern and Southern Hemisphere. For example, Southern Hemisphere countries such as Argentina, Chile, southern Brazil, and South Africa had much larger epidemics than expected based on mobility, testing, and mask use. The statistical association between COVID-19 transmission rates and pneumonia seasonality patterns is strong and is the basis for our estimate of the magnitude of the seasonal increase that is expected.
• If a herd immunity strategy is pursued, meaning no further government intervention is taken from now to January 1, then the death toll could increase to 611,784 by January 1. Compared to the reference scenario, this would be 196,694 more deaths from now to the end of the year.
• Increasing mask use remains an extraordinary opportunity for the US. Increasing mask use to the levels seen in Singapore would decrease the cumulative US death toll to 298,589, or 116,501 lives saved compared to the reference scenario.
Model updates
• Clinical experience suggests that case management of COVID-19 has improved through oxygenation/ventilation methods and use of dexamethasone and remdesivir. This improved management would manifest itself as a reduction in the infection-fatality rate at each age. We have looked for statistical evidence of this shift in two ways. First, we have examined the COVID-19 admission-fatality rate – the number of deaths divided by hospital admissions. To date, the admission-fatality rate has remained constant since April. This could be explained by
United States Model updates for September 11, 2020
covid.healthdata.org Institute for Health Metrics and Evaluation
two possible factors: either there is no change in the infection-fatality rate or the infection-fatality rate has declined and hospitals are admitting only more severe patients over time. Second, we have looked at the directly measured infection-fatality rate using seroprevalence studies. To date, we have not detected any statistically significant decrease in the infection-fatality rate. We will continue testing on a regular basis for statistical evidence of the infection-fatality rate declining.
United States of America MODEL UPDATES
COVID-19 Results Briefing: United States of America
Institute for Health Metrics and Evaluation (IHME)
September 11, 2020
This briefing contains summary information on the latest projections from the IHME model on COVID-19 inUnited States of America. The model was run on September 10, 2020.
Model updates
Updates to the model this week include additional data on deaths, cases, and updates on covariates.
covid19.healthdata.org 1 Institute for Health Metrics and Evaluation
United States of America CURRENT SITUATION
Current situation
Figure 1. Reported daily COVID-19 cases
0
20,000
40,000
60,000
80,000
Apr May Jun Jul Aug SepMonth
Cou
nt
Daily cases
covid19.healthdata.org 2 Institute for Health Metrics and Evaluation
United States of America CURRENT SITUATION
Table 1. Ranking of COVID-19 among the leading causes of mortality this week, assuming uniform deathsof non-COVID causes throughout the year
Cause name Weekly deaths RankingIschemic heart disease 10,724 1COVID-19 5,984 2Tracheal, bronchus, and lung cancer 3,965 3Chronic obstructive pulmonary disease 3,766 4Stroke 3,643 5Alzheimer’s disease and other dementias 2,768 6Chronic kidney disease 2,057 7Colon and rectum cancer 1,616 8Lower respiratory infections 1,575 9Diabetes mellitus 1,495 10
Figure 2a. Reported daily COVID-19 deaths and smoothed trend estimate
0
1,000
2,000
Apr May Jun Jul Aug Sep
Dai
ly d
eath
s
covid19.healthdata.org 3 Institute for Health Metrics and Evaluation
United States of America CURRENT SITUATION
Figure 2b. Estimated cumulative deaths by age group
0
5
10
15
<5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 99Age group
Sha
re o
f cum
ulat
ive
deat
hs, %
Figure 3. Mean effective R on August 28, 2020. The estimate of effective R is based on the combined analysisof deaths, case reporting and hospitalizations where available. Current reported cases reflect infections 11-13days prior so estimates of effective R can only be made for the recent past. Effective R less than 1 meansthat transmission should decline all other things being held the same.
<0.84
0.84−0.87
0.88−0.91
0.92−0.95
0.96−0.99
1−1.03
1.04−1.07
1.08−1.11
1.12−1.15
>=1.16
covid19.healthdata.org 4 Institute for Health Metrics and Evaluation
United States of America CURRENT SITUATION
Figure 4. Estimated percent infected with COVID-19 on September 08, 2020
<1
1−3.9
4−6.9
7−9.9
10−12.9
13−16.4
16.5−19.4
19.5−22.4
22.5−25.4
>=25.5
Figure 5. Percent of COVID-19 infections detected. This is estimated as the ratio of reported COVID-19cases to estimated COVID-19 infections based on the SEIR model.
0
20
40
Feb Mar Apr May Jun Jul Aug Sep
Per
cent
of i
nfec
tions
det
ecte
d
Republic of Korea Italy United Kingdom United States of America
covid19.healthdata.org 5 Institute for Health Metrics and Evaluation
United States of America CURRENT SITUATION
Figure 6. Daily COVID-19 death rate per 1 million on September 08, 2020
<1
1 to 1.9
2 to 2.9
3 to 3.9
4 to 4.9
5 to 5.9
6 to 6.9
7 to 7.9
>=8
covid19.healthdata.org 6 Institute for Health Metrics and Evaluation
United States of America CRITICAL DRIVERS
Critical drivers
Table 2. Current mandate implementation
All
gath
erin
gs r
estr
icte
d
All
none
ssen
tial b
usin
esse
s cl
osed
Any
bus
ines
ses
rest
ricte
d
Mas
k us
e
Sch
ool c
losu
re
Sta
y ho
me
orde
r
Trav
el li
mits
WyomingWisconsin
West VirginiaWashington
VirginiaVermont
UtahTexas
TennesseeSouth Dakota
South CarolinaRhode IslandPennsylvania
OregonOklahoma
OhioNorth Dakota
North CarolinaNew York
New MexicoNew Jersey
New HampshireNevada
NebraskaMontanaMissouri
MississippiMinnesota
MichiganMassachusetts
MarylandMaine
LouisianaKentucky
KansasIowa
IndianaIllinoisIdaho
HawaiiGeorgiaFlorida
District of ColumbiaDelaware
ConnecticutColoradoCaliforniaArkansas
ArizonaAlaska
Alabama
Mandate in place No mandate
covid19.healthdata.org 7 Institute for Health Metrics and Evaluation
United States of America CRITICAL DRIVERS
Figure 7. Total number of mandates
WyomingWisconsin
West VirginiaWashington
VirginiaVermont
UtahTexas
TennesseeSouth Dakota
South CarolinaRhode IslandPennsylvania
OregonOklahoma
OhioNorth Dakota
North CarolinaNew York
New MexicoNew Jersey
New HampshireNevada
NebraskaMontanaMissouri
MississippiMinnesota
MichiganMassachusetts
MarylandMaine
LouisianaKentucky
KansasIowa
IndianaIllinoisIdaho
HawaiiGeorgiaFlorida
District of ColumbiaDelaware
ConnecticutColoradoCaliforniaArkansas
ArizonaAlaska
Alabama
Feb Mar Apr May Jun Jul Aug Sep
# of mandates
0
1
2
3
4
5
6
Mandate imposition timing
covid19.healthdata.org 8 Institute for Health Metrics and Evaluation
United States of America CRITICAL DRIVERS
Figure 8a. Trend in mobility as measured through smartphone app use compared to January 2020 baseline
−80
−60
−40
−20
0
Jan Feb Mar Apr May Jun Jul Aug Sep
Per
cent
red
uctio
n fr
om a
vera
ge m
obili
ty
Republic of Korea Italy United Kingdom United States of America
Figure 8b. Mobility level as measured through smartphone app use compared to January 2020 baseline(percent)
=<−50
−49 to −45
−44 to −40
−39 to −35
−34 to −30
−29 to −25
−24 to −20
−19 to −15
−14 to −10
>−10
covid19.healthdata.org 9 Institute for Health Metrics and Evaluation
United States of America CRITICAL DRIVERS
Figure 9a. Trend in the proportion of the population reporting always wearing a mask when leaving home
0
25
50
75
Jan Feb Mar Apr May Jun Jul Aug Sep
Per
cent
of p
opul
atio
n
Republic of Korea Italy United Kingdom United States of America
Figure 9b. Proportion of the population reporting always wearing a mask when leaving home on September08, 2020
<30%
30 to 34%
35 to 39%
40 to 44%
45 to 49%
50 to 54%
55 to 59%
60 to 64%
65 to 69%
>=70
covid19.healthdata.org 10 Institute for Health Metrics and Evaluation
United States of America CRITICAL DRIVERS
Figure 10a. Trend in COVID-19 diagnostic tests per 100,000 people
0
100
200
Feb Mar Apr May Jun Jul Aug Sep
Test
per
100
,000
pop
ulat
ion
Republic of Korea Italy United Kingdom United States of America
Figure 10b. COVID-19 diagnostic tests per 100,000 people on September 03, 2020
<5
5 to 9.9
10 to 24.9
25 to 49
50 to 149
150 to 249
250 to 349
350 to 449
450 to 499
>=500
covid19.healthdata.org 11 Institute for Health Metrics and Evaluation
United States of America CRITICAL DRIVERS
Figure 11. Increase in the risk of death due to pneumonia on February 1 compared to August 1
<−80%
−80 to −61%
−60 to −41%
−40 to −21%
−20 to −1%
0 to 19%
20 to 39%
40 to 59%
60 to 79%
>=80%
covid19.healthdata.org 12 Institute for Health Metrics and Evaluation
United States of America PROJECTIONS AND SCENARIOS
Projections and scenarios
We produce three scenarios when projecting COVID-19. The reference scenario is our forecast of what wethink is most likely to happen. We assume that if the daily mortality rate from COVID-19 reaches 8 permillion, social distancing (SD) mandates will be re-imposed. The mandate easing scenario is what wouldhappen if governments continue to ease social distancing mandates with no re-imposition. The universal maskmandate scenario is what would happen if mask use increased immediately to 95% and social distancingmandates were re-imposed at 8 deaths per million.
Figure 12. Cumulative COVID-19 deaths until January 01, 2021 for three scenarios.
0
200,000
400,000
600,000
0
100
200
300
400
500
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan
Cum
ulat
ive
deat
hsC
umulative deaths per 100,000
Continued SD mandate easing
Reference scenario
Universal mask use
Fig 13. Daily COVID-19 deaths until January 01, 2021 for three scenarios.
0
2,500
5,000
7,500
10,000
12,500
0.0
2.5
5.0
7.5
10.0
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan
Dai
ly d
eath
sD
aily deaths per 100,000
Continued SD mandate easing
Reference scenario
Universal mask use
covid19.healthdata.org 13 Institute for Health Metrics and Evaluation
United States of America PROJECTIONS AND SCENARIOS
Fig 14. Daily COVID-19 infections until January 01, 2021 for three scenarios.
0
500,000
1,000,000
1,500,000
0
500
1000
1500
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan
Dai
ly in
fect
ions
Daily infections per 100,000
Continued SD mandate easing
Reference scenario
Universal mask use
Fig 15. Month of assumed mandate re-implementation. (Month when daily death rate passes 8 per million,when reference scenario model assumes mandates will be re-imposed.)
September
October
November
DecemberNo mandates before Jan 1
covid19.healthdata.org 14 Institute for Health Metrics and Evaluation
United States of America PROJECTIONS AND SCENARIOS
Figure 16. Forecasted percent infected with COVID-19 on January 01, 2021
<1
1−3.9
4−6.9
7−9.9
10−12.9
13−16.4
16.5−19.4
19.5−22.4
22.5−25.4
>=25.5
Figure 17. Daily COVID-19 deaths per million forecasted on January 01, 2021 in the reference scenario
<1
1 to 1.9
2 to 2.9
3 to 3.9
4 to 4.9
5 to 5.9
6 to 6.9
7 to 7.9
>=8
covid19.healthdata.org 15 Institute for Health Metrics and Evaluation
United States of America PROJECTIONS AND SCENARIOS
Table 3. Ranking of COVID-19 among the leading causes of mortality in the full year 2020. Deaths fromCOVID-19 are projections of cumulative deaths on Jan 1, 2021 from the reference scenario. Deaths fromother causes are from the Global Burden of Disease study 2019 (rounded to the nearest 100).
Cause name Annual deaths RankingIschemic heart disease 557,600 1COVID-19 415,090 2Tracheal, bronchus, and lung cancer 206,200 3Chronic obstructive pulmonary disease 195,800 4Stroke 189,500 5Alzheimer’s disease and other dementias 143,900 6Chronic kidney disease 107,000 7Colon and rectum cancer 84,000 8Lower respiratory infections 81,900 9Diabetes mellitus 77,700 10
Mask data source: Premise; Facebook Global symptom survey (This research is based on survey resultsfrom University of Maryland Social Data Science Center); Kaiser Family Foundation; YouGov COVID-19Behaviour Tracker survey
A note of thanks:
We would like to extend a special thanks to the Pan American Health Organization (PAHO) for keydata sources; our partners and collaborators in Argentina, Brazil, Bolivia, Chile, Colombia, Cuba, theDominican Republic, Ecuador, Egypt, Honduras, Israel, Japan, Malaysia, Mexico, Moldova, Panama, Peru,the Philippines, Russia, Serbia, South Korea, Turkey, and Ukraine for their support and expert advice; andto the tireless data collection and collation efforts of individuals and institutions throughout the world.
In addition, we wish to express our gratitude for efforts to collect social distancing policy information inLatin America to University of Miami Institute for Advanced Study of the Americas (Felicia Knaul, MichaelTouchton), with data published here: http://observcovid.miami.edu/; Fundación Mexicana para la Salud(Héctor Arreola-Ornelas) with support from the GDS Services International: Tómatelo a Pecho A.C.; andCentro de Investigaciones en Ciencias de la Salud, Universidad Anáhuac (Héctor Arreola-Ornelas); Lab onResearch, Ethics, Aging and Community-Health at Tufts University (REACH Lab) and the University ofMiami Institute for Advanced Study of the Americas (Thalia Porteny).
Further, IHME is grateful to the Microsoft AI for Health program for their support in hosting our COVID-19data visualizations on the Azure Cloud. We would like to also extend a warm thank you to the many otherswho have made our COVID-19 estimation efforts possible.
covid19.healthdata.org 16 Institute for Health Metrics and Evaluation